Novo Nordisk may attempt to mitigate the impact from off-patent competition by protecting their share of Wegovy by enhancing weight-management services, or migrating patients from semaglutide to newer, patent-protected AOMs, including offering an oral version of semaglutide, effectively offering therapies with greater patient benefits
People who stop taking these medications without making changes to their eating habits and lifestyle risk regaining the weight lost
Barry Road, Kansas City, MO, 64154 Gladstone (816) 505-5505 6110 N.W
High intake of fruits, vegetables, whole grains lower chronic disease rates
It also influences brain receptors that control cravings , leading to a more natural reduction in hunger over time
We counsel patients who could become pregnant to use appropriate birth control while theyre on these medications, Dr